Cancer Blood Test Detects Tumors Early

A microfluidic device the size of two quarters has the ability to catch and release circulating tumor cells (CTCs) — cancer cells that circulate in a cancer patient's blood. Such a device could lead to earlier detection of primary tumors and metastasis, as well as determine the effectiveness of treatment — all through a simple, noninvasive blood test.